936 related articles for article (PubMed ID: 28474229)
1. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
[TBL] [Abstract][Full Text] [Related]
2. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder.
Joshi G; DiSalvo M; Wozniak J; Ceranoglu TA; Yule A; Surman C; Fried R; Galdo M; Hoskova B; Belser A; Biederman J
World J Biol Psychiatry; 2020 Apr; 21(4):274-290. PubMed ID: 31607204
[No Abstract] [Full Text] [Related]
3. Processing speed as a marker to stimulant effect in clinical sample of children with high functioning autism spectrum disorder.
Peled J; Cassuto H; Berger I
Nord J Psychiatry; 2020 Apr; 74(3):163-167. PubMed ID: 31686565
[No Abstract] [Full Text] [Related]
4. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
5. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
[TBL] [Abstract][Full Text] [Related]
6. Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Pearson DA; Santos CW; Aman MG; Arnold LE; Lane DM; Loveland KA; Mansour R; Ward AR; Casat CD; Jerger S; Schachar RJ; Bukstein OG; Cleveland LA
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):414-426. PubMed ID: 32644833
[No Abstract] [Full Text] [Related]
7. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
8. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
9. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
10. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
11. ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.
Stevanovic D; Wentz E; Nasic S; Knez R
BMC Psychiatry; 2022 Apr; 22(1):282. PubMed ID: 35448977
[TBL] [Abstract][Full Text] [Related]
12. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
[TBL] [Abstract][Full Text] [Related]
13. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
Pearson DA; Santos CW; Aman MG; Arnold LE; Casat CD; Mansour R; Lane DM; Loveland KA; Bukstein OG; Jerger SW; Factor P; Vanwoerden S; Perez E; Cleveland LA
J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):337-51. PubMed ID: 23782128
[TBL] [Abstract][Full Text] [Related]
14. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
Dalsgaard S; Nielsen HS; Simonsen M
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
[TBL] [Abstract][Full Text] [Related]
15. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
16. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
[TBL] [Abstract][Full Text] [Related]
17. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
Konstenius M; Jayaram-Lindström N; Beck O; Franck J
Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
[TBL] [Abstract][Full Text] [Related]
18. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.
Scahill L; Bearss K; Sarhangian R; McDougle CJ; Arnold LE; Aman MG; McCracken JT; Tierney E; Gillespie S; Postorino V; Vitiello B
J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):125-131. PubMed ID: 27893955
[TBL] [Abstract][Full Text] [Related]
19. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.
Baziar S; Aqamolaei A; Khadem E; Mortazavi SH; Naderi S; Sahebolzamani E; Mortezaei A; Jalilevand S; Mohammadi MR; Shahmirzadi M; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):205-212. PubMed ID: 30741567
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
